Clinical Trials

15 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms, Respiratory Tract Neoplasms

NCT01636908 2021-04-15

ICK

Phase NA Completed

43 enrolled

Neoplasms

NCT02714530 2021-03-30

ThoRaT

118 enrolled

Neoplasms

NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Phase NA Unknown

15 enrolled

CNS

Glioma, Neoplasms

NCT02117024 2020-02-05

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

66 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00848718 2019-11-12

MK-2206-003

77 enrolled 24 charts

Neoplasms

NCT01545947 2019-11-12

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

76 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00497224 2019-05-30

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

51 enrolled

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

23 enrolled

Lung Neoplasms, Neoplasms

NCT01518621 2019-03-13

RadEr

25 enrolled

Neoplasms

NCT01376310 2019-02-19

GSK1120212 Rollover Study

159 enrolled 9 charts

Neoplasms

NCT00954512 2018-08-24

Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)

Phase 1/2 Terminated

15 enrolled 11 charts

Neoplasms

NCT02134015 2018-01-23

HER3-Lung

Phase 3 Terminated

145 enrolled 20 charts

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03389256 2018-01-03

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Phase 2 Unknown

144 enrolled

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT01472016 2017-11-21

Study of ABT-700 in Subjects With Advanced Solid Tumors

74 enrolled

Neoplasms

NCT01192165 2017-11-13

Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel

169 enrolled

Neoplasms

NCT00369512 2017-05-30

RAD0503

15 enrolled 9 charts

Carcinoma, Squamous Cell, Neoplasms

NCT00841035 2017-05-19

7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients

6 enrolled 3 charts

Neoplasms, Pancreatic Neoplasms

NCT01482377 2017-01-27

A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin

145 enrolled

Neoplasms

NCT00491816 2017-01-19

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Phase 2 Unknown

32 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT02015728 2016-12-15

SEED

Phase NA Unknown

20 enrolled

Neoplasms, Recurrence

NCT00811993 2016-11-02

A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors

Phase 1 Terminated

104 enrolled

Neoplasms

NCT00336700 2016-09-19

A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer

25 enrolled 10 charts

Neoplasms, Pancreatic Neoplasms

NCT00705874 2016-07-21

Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma

172 enrolled 13 charts

Lymphoid

Lymphoma, Neoplasms

NCT00207077 2015-10-28

Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors

33 enrolled

Neoplasms

NCT00585377 2015-09-24

Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer

50 enrolled 7 charts

Neoplasms

NCT00109265 2015-07-02

A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy

Breast

Breast Neoplasms, Neoplasms

NCT01727869 2015-04-06

Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer

56 enrolled

Neoplasms

NCT00642746 2014-09-26

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

16 enrolled 9 charts

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT01565538 2014-09-15

Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma

123 enrolled 9 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT02034097 2014-05-19

A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00884845 2014-03-26

Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors

35 enrolled

Neoplasms

NCT00725634 2014-01-27

P05538